PTC Therapeutics, Inc. (PTCT) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 272.55M | 164.68M | 211.01M | 178.88M | 1.18B | 213.17M | 196.79M | 186.7M | 210.12M | 307.06M | 196.58M | 213.81M |
| Revenue Growth % | -76.83% | -22.75% | 7.23% | -4.19% | 459.73% | -30.58% | 0.11% | -12.68% | -4.66% | 83.41% | -9.46% | 29.17% |
| Cost of Goods Sold | 39.61M | 16.3M | 115.94M | 11.42M | 12.86M | 16.28M | 10.85M | 15.53M | 14.74M | 106.29M | 9.49M | 12.73M |
| COGS % of Revenue | 14.53% | 9.9% | 54.95% | 6.38% | 1.09% | 7.64% | 5.51% | 8.32% | 7.02% | 34.62% | 4.83% | 5.95% |
| Gross Profit | 232.94M | 148.38M | 95.07M | 167.46M | 1.16B | 196.89M | 185.94M | 171.18M | 195.38M | 200.76M | 187.08M | 201.08M |
| Gross Margin % | 85.47% | 90.1% | 45.05% | 93.62% | 98.91% | 92.36% | 94.49% | 91.68% | 92.98% | 65.38% | 95.17% | 94.05% |
| Gross Profit Growth % | -79.97% | -24.64% | -48.87% | -2.17% | 495.38% | -1.93% | -0.61% | -14.87% | -5.27% | 28.27% | -7.89% | 28.99% |
| Operating Expenses | 187.06M | 230M | 92.05M | 202.41M | 193.01M | 359.28M | 240.45M | 211.4M | 240.83M | 197.64M | 305.25M | 410.62M |
| OpEx % of Revenue | 68.63% | 139.67% | 43.63% | 113.16% | 16.41% | 168.54% | 122.19% | 113.22% | 114.62% | 64.37% | 155.28% | 192.05% |
| Selling, General & Admin | 86.18M | 100.47M | 84.05M | 85.26M | 80.96M | 84.68M | 73.46M | 69.5M | 73.27M | 76.29M | 80.89M | 88.45M |
| SG&A % of Revenue | 31.62% | 61.01% | 39.83% | 47.67% | 6.88% | 39.73% | 37.33% | 37.22% | 34.87% | 24.85% | 41.15% | 41.37% |
| Research & Development | 100.87M | 133.13M | 100.16M | 112.99M | 108.97M | 124.77M | 161.41M | 132.17M | 116.13M | 121.35M | 164.21M | 185.87M |
| R&D % of Revenue | 37.01% | 80.84% | 47.47% | 63.17% | 9.27% | 58.53% | 82.02% | 70.79% | 55.27% | 39.52% | 83.54% | 86.94% |
| Other Operating Expenses | 0 | -1000K | -1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 1000K | 1000K |
| Operating Income | 45.89M | -81.62M | 3.02M | -34.96M | 970.23M | -162.39M | -54.51M | -40.22M | -45.45M | 3.12M | -118.16M | -209.54M |
| Operating Margin % | 16.84% | -49.57% | 1.43% | -19.54% | 82.5% | -76.18% | -27.7% | -21.54% | -21.63% | 1.02% | -60.11% | -98.01% |
| Operating Income Growth % | -95.27% | 49.74% | 105.53% | 13.08% | 2234.57% | -5304.78% | 53.87% | 80.81% | 61.35% | 101.56% | -60.8% | -126.87% |
| EBITDA | 61.3M | -68.72M | 14.13M | -27.37M | 977.45M | -155.63M | -48.02M | -33.2M | 9.94M | 83.83M | -53.63M | -158.54M |
| EBITDA Margin % | 22.49% | -41.73% | 6.69% | -15.3% | 83.11% | -73% | -24.4% | -17.78% | 4.73% | 27.3% | -27.28% | -74.15% |
| EBITDA Growth % | -93.73% | 55.84% | 129.41% | 17.55% | 9731.48% | -285.65% | 10.45% | 79.06% | 113.29% | 151.91% | -49.8% | -150.92% |
| D&A (Non-Cash Add-back) | 15.41M | 12.9M | 11.11M | 7.58M | 7.22M | 6.76M | 6.49M | 7.02M | 55.4M | 80.7M | 64.54M | 51.01M |
| EBIT | 45.89M | -83.89M | 9.52M | -40.69M | 963.92M | -53.64M | -56.38M | -42.24M | -43.86M | -112.78M | -138.43M | -208.06M |
| Net Interest Income | 49.03M | -55.19M | -32.59M | -30.36M | -34.09M | -41.06M | -41.61M | -43.49M | -40.83M | -44.27M | -28.16M | -29.41M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | -49.03M | 55.19M | 32.59M | 30.36M | 34.09M | 41.06M | 41.61M | 43.49M | 40.83M | 44.27M | 28.16M | 29.41M |
| Other Income/Expense | -48.35M | -57.46M | -26.09M | -36.09M | -40.4M | 67.69M | -43.48M | -45.52M | -39.24M | -160.17M | -48.43M | -27.94M |
| Pretax Income | -2.46M | -139.08M | -23.07M | -71.05M | 929.83M | -94.7M | -97.99M | -85.73M | -84.7M | -157.05M | -166.59M | -237.48M |
| Pretax Margin % | -0.9% | -84.46% | -10.94% | -39.72% | 79.06% | -44.42% | -49.8% | -45.92% | -40.31% | -51.15% | -84.75% | -111.07% |
| Income Tax | 347K | -4.12M | -38.97M | -6.2M | 63.27M | -28.81M | 8.66M | 13.45M | 6.88M | -1.26M | -33.62M | -38.6M |
| Effective Tax Rate % | -14.09% | 2.96% | 168.89% | 8.73% | 6.8% | 30.43% | -8.84% | -15.68% | -8.12% | 0.8% | 20.18% | 16.25% |
| Net Income | -2.81M | -134.97M | 15.9M | -64.85M | 866.56M | -65.89M | -106.65M | -99.18M | -91.58M | -155.79M | -132.97M | -198.88M |
| Net Margin % | -1.03% | -81.96% | 7.53% | -36.25% | 73.68% | -30.91% | -54.2% | -53.12% | -43.58% | -50.74% | -67.64% | -93.02% |
| Net Income Growth % | -100.32% | -104.85% | 114.9% | 34.61% | 1046.28% | 57.71% | 19.79% | 50.13% | 34.1% | 8.83% | -21.64% | -30.77% |
| Net Income (Continuing) | -2.81M | -134.97M | 15.9M | -64.85M | 866.56M | -65.89M | -106.65M | -99.18M | -91.58M | -155.79M | -132.97M | -198.88M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.03 | -1.67 | 0.20 | -0.83 | 10.04 | -0.85 | -1.39 | -1.29 | -1.20 | -2.06 | -1.76 | -2.66 |
| EPS Growth % | -100.34% | -96.47% | 114.39% | 35.66% | 936.67% | 58.74% | 21.02% | 51.5% | 36.17% | 12.34% | -15.03% | -24.88% |
| EPS (Basic) | -0.03 | -1.67 | 0.20 | -0.83 | 11.09 | -0.85 | -1.39 | -1.29 | -1.20 | -2.06 | -1.76 | -2.66 |
| Diluted Shares Outstanding | 82.52M | 80.69M | 87.12M | 78.15M | 86.39M | 77.2M | 76.93M | 76.73M | 76.5M | 75.51M | 75.38M | 74.73M |
| Basic Shares Outstanding | 82.52M | 80.69M | 81.5M | 78.15M | 78.12M | 77.2M | 76.93M | 76.73M | 76.5M | 75.51M | 75.38M | 74.73M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |